It has come to Mediclinic’s attention that an article released earlier this month by CNBC may have caused concern about the mechanism of spread of SARS-CoV-2, the virus that causes COVID-19.

As highlighted by the World Health Organization (WHO) in their responding statement, the conditions of the test referred to in the publication does not replicate conditions relating to coughing or sneezing. Available evidence indicates that that SARS-CoV-2 virus is transmitted during close contact through respiratory droplets (such as coughing) and by objects. The virus can spread directly from person to person when a COVID-19 case coughs or exhales, producing droplets that can reach the nose, mouth or eyes of another person if they are in close proximity to one another. According to the currently available evidence, transmission through smaller droplet nuclei (airborne transmission) that propagate through air at distances longer than 1 meter is limited to aerosol generating procedures during clinical care of COVID-19 patients.

With this in mind, Mediclinic assures the public that we continue to follow the strict protocols released by the National Institute for Communicable Diseases (NICD) and the WHO, in order to prevent the transmission of the virus in our facilities and to protect our patients, staff and doctors.

We also urge the public to critically validate any COVID-19 related information before communicating it further via social media channels. To this end, we advise that the WHO is seen as one of the most credible sources of accurate information in this regard.

Mediclinic is committed to playing a vital role in supporting the nation during this crisis. We believe that it is essential to co-ordinate all our efforts with those of WHO, Government and the Department of Health to ensure the most effective response to the pandemic.


For further information please contact:

Mediclinic Southern Africa
Tertia Kruger: Corporate Communication Manager
Tel: 021 809 6500